deoxyglucose has been researched along with Hodgkin Disease in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (88.89) | 18.2507 |
2000's | 2 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banning, U; Barthel, H; Kluge, R; Körholz, D; Mauz-Körholz, C; Sabri, O | 1 |
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Lorenz, WJ; Maier-Borst, W; Strauss, LG; van Kaick, G | 1 |
Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K | 1 |
Bergman, J; Knuuti, MJ; Lindholm, P; Minn, H; Nuutila, P; Ruotsalainen, U; Teräs, M | 1 |
Francis, IR; Kaminski, MS; Newman, JS; Wahl, RL | 1 |
Bares, R; Büll, U; Dempke, W; Galonska, P; Handt, S; Osieka, R | 1 |
Aberle, DR; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Phelps, ME; Razavi, MK; Rege, SD | 1 |
Golding, R; Hoekstra, OS; Huijgens, PC; Ossenkoppele, GJ; Teule, GJ; van Lingen, A; Visser, GW | 1 |
Dahlbom, M; Glaspy, J; Hawkin, RA; Hoh, CK; Kunkel, L; Lee, SJ; Maddahi, J; Phelps, ME; Rosen, P | 1 |
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hegenbart, U; Irngartinger, G; Oberdorfer, F; Strauss, LG; van Kaick, G | 1 |
Bangerter, M; Diederichs, CG; Guhlmann, A; Herrmann, F; Kolokythas, O; Kotzerke, J; Merkle, E; Moog, F; Reske, SN | 1 |
Beyer, W; Bumann, D; Clausen, M; de Wit, M; Herbst, K; Hossfeld, DK | 1 |
Babchyck, B; Belakhlef, A; Kochen, J; Weinblatt, ME; Zanzi, I | 1 |
Altehoefer, C; Buchmann, I; Bunjes, D; Elsner, K; Finke, J; Glatting, G; Guhlmann, CA; Kotzerke, J; Moser, E; Reinhardt, M; Reske, SN; Schirrmeister, H | 1 |
Green, MV; Herscheid, KD; Hoekstra, OS; Huijgens, PC; Huitink, H; Martens, HJ; Ossenkoppele, GJ; Teule, GJ; van Lingen, A; Visser, FC | 1 |
Bischoff, H; Knopp, MV; Oberdorfer, F; van Kaick, G | 1 |
Arimizu, N; Imaseki, K; Itami, J; Itami, M; Kuyama, J; Mikata, A; Okada, J; Uno, K; Yoshikawa, K | 1 |
Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K | 1 |
1 review(s) available for deoxyglucose and Hodgkin Disease
Article | Year |
---|---|
[Positron emission tomography of the thorax. The current clinical status].
Topics: Carcinoma, Bronchogenic; Deoxyglucose; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Tomography, Emission-Computed | 1992 |
2 trial(s) available for deoxyglucose and Hodgkin Disease
Article | Year |
---|---|
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.
Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Whole-Body Counting | 1997 |
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Topics: Adolescent; Adult; Aged; Antimetabolites; Biopsy; Bone Marrow; Deoxyglucose; Female; Fluorine Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
15 other study(ies) available for deoxyglucose and Hodgkin Disease
Article | Year |
---|---|
Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells.
Topics: 4-Chloro-7-nitrobenzofurazan; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; B-Lymphocytes; Caspases; Cell Death; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Deoxyglucose; Energy Metabolism; Etoposide; False Negative Reactions; Hodgkin Disease; Humans; Neoplasm Proteins | 2006 |
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Oxygen Radioisotopes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Water | 1995 |
FDG-PET for predicting the prognosis of malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, Emission-Computed | 1994 |
In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Hodgkin Disease; Humans; Insulin; Insulin Resistance; Lymphoma; Male; Middle Aged; Muscles; Tomography, Emission-Computed | 1994 |
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Topics: Adolescent; Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed | 1993 |
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Thoracic Neoplasms; Tomography, Emission-Computed | 1993 |
Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Remission Induction; Tomography, Emission-Computed, Single-Photon | 1993 |
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
Topics: Adolescent; Adult; Aged; Algorithms; Biopsy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Health Care Costs; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Tomography, Emission-Computed | 1997 |
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Combined Modality Therapy; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1997 |
False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease.
Topics: Child; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Thymus Neoplasms; Tomography, Emission-Computed | 1997 |
Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera.
Topics: Adult; Deoxyglucose; Fluorodeoxyglucose F18; Gamma Cameras; Hodgkin Disease; Humans; Middle Aged; Myocardial Infarction; Thallium Radioisotopes; Tomography, Emission-Computed | 1992 |
Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.
Topics: Adult; Aged; Aged, 80 and over; Cell Division; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Nuclear Proteins; Tomography, Emission-Computed | 1992 |
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1991 |